Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/26196
Title: | The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer | Authors: | Perloy, Andy Schouten, Leo J. van den Brandt, Piet A. Godschalk, Roger VAN SCHOOTEN, Frederik-Jan HOGERVORST, Janneke |
Issue Date: | 2018 | Source: | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 70(4), p. 620-631 | Abstract: | To investigate the association between dietary acrylanide and advanced prostate cancer, we examined acrylamide-gene interactions for advanced prostate cancer risk by using data from the Netherlands Cohort Study.Participants (n = 58,279 men) completed a baseline food frequency questionnaire (FFQ), from which daily acrylamide intake was calculated. At baseline, 2,411 men were randomly selected from the full cohort for case-cohort analysis. Fifty eight selected single nucleotide polymorphisms (SNPs) and two gene deletions in genes in acrylamide metabolism, DNA repair, sex steroid systems, and oxidative stress were analyzed. After 20.3years of follow-up, 1,608 male subcohort members and 948 advanced prostate cancer cases were available for Cox analysis.Three SNPs showed a main association with advanced prostate cancer risk after multiple testing correction: catalase (CAT) rs511895, prostaglandin-endoperoxide synthase 2 (PTGS2) rs5275, and xeroderma pigmentosum group C (XPC) rs2228001. With respect to acrylamide-gene interactions, only rs1800566 in NAD(P)H quinone dehydrogenase 1 (NQO1) and rs2301241 in thioredoxin (TXN) showed a nominally statistically significant multiplicative interaction with acrylamide intake for advanced prostate cancer risk. After multiple testing corrections, none were statistically significant.In conclusion, no clear evidence was found for interaction between acrylamide intake and selected genetic variants for advanced prostate cancer risk. | Notes: | Schouten, LJ (reprint author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands. lj.schouten@maastrichtuniversity.nl | Document URI: | http://hdl.handle.net/1942/26196 | ISSN: | 0163-5581 | e-ISSN: | 1532-7914 | DOI: | 10.1080/01635581.2018.1460682 | ISI #: | 000432214600009 | Rights: | © 2018 Andy Perloy, Leo J. Schouten, Piet A. van den Brandt, Roger Godschalk, Frederik-Jan van Schooten, and Janneke G. F. Hogervorst. Published with license by Taylor & Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2019 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
perloy 1.pdf | Published version | 841.51 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
2
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
6
checked on Jul 13, 2024
Page view(s)
88
checked on Sep 7, 2022
Download(s)
120
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.